| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |